Megan Hovermale, NP
Adult Health · Las Vegas, NVNPI 1790072114
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,075 of the $2,853 with a category attached, or 72.7%. 15 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 33.4% of the total. Reporting peaked in 2022 at $1,053 and has fallen 55.5% since, to $469 in 2025.
Across 87 payments — averaging $32.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$953
- Pacira Therapeutics, Inc.$443
- Ferring Pharmaceuticals Inc.$393
- Smith+Nephew$319
- Amgen$184
- Linvatec Corporation$103
- plus $457 from 9 others
What the payments were for
- Travel & lodging$77827%
- Food & beverage$2,07573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 7 | $953 |
| Pacira Therapeutics, Inc. | 16 | $443 |
| Ferring Pharmaceuticals Inc. | 31 | $393 |
| Smith+Nephew | 3 | $319 |
| Amgen(2 entities) | 7 | $184 |
| Linvatec Corporation | 3 | $103 |
| Boston Scientific | 6 | $100 |
| Goode Surgical Inc | 4 | $100 |
| Vericel Corporation | 1 | $90 |
| Radius Health, Inc. | 3 | $60 |
| Orthofix Medical, Inc. | 2 | $41 |
| Organogenesis Inc. | 1 | $26 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Dynasplint Systems Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,853 in reported general payments places this provider in the 80th percentile of 90 adult health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $1,105 |
| Celecoxib | 16 | $603 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $295 |
| Gabapentin | 39 | $112 |
| Methocarbamol | 23 | $93 |
| Amoxicillin | 16 | $36 |
Paid to pharmacies, not to this prescriber.
Other adult health in Las Vegas
- Marcia Castro-RosenbergLas Vegas$64K
- Amanda SquiersLas Vegas$36K
- Jasmina FornbacherLas Vegas$14K
- Marcella PomeranzLas Vegas$14K
- Karisa SonLas Vegas$10K
- Jessica LuceroLas Vegas$6K
- Monica LynamLas Vegas$5K
- Thomas McNeilLas Vegas$5K
- Roger ConantLas Vegas$4K
- Ruth RamirezLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.